This dichotomy is also observed in different breast cancer subsets, where PI3K promotes Wnt/β-catenin activation in ER+ breast cancers, but suppresses this pathway in ER− breast cancers, as discussed in more detail below. Here, PIK3CA is linked to breast carcinoma.